发明授权
- 专利标题: SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS
- 专利标题(中): 取代的三唑催产素
-
申请号: EP06710566.8申请日: 2006-03-08
-
公开(公告)号: EP1863795B1公开(公告)日: 2008-10-29
- 发明人: CALABRESE, Andrew, Antony
- 申请人: Pfizer Limited
- 申请人地址: Ramsgate Road Sandwich, Kent CT13 9NJ GB
- 专利权人: Pfizer Limited
- 当前专利权人: Pfizer Limited
- 当前专利权人地址: Ramsgate Road Sandwich, Kent CT13 9NJ GB
- 代理机构: Nevant, Marc
- 优先权: US664091P 20050321
- 国际公布: WO2006100557 20060928
- 主分类号: C07D401/14
- IPC分类号: C07D401/14 ; A61K31/497 ; A61P5/10
摘要:
The present invention relates to a class of substituted triazoles of formula (I) with activity as oxytocin antagonists, uses thereof, processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction, particularly premature ejaculation (P.E.).
公开/授权文献
- EP1863795A1 SUBSTITUTED TRIAZOLE DERIVATIVES AS OXYTOCIN ANTAGONISTS 公开/授权日:2007-12-12
信息查询